ImmunityBio has surged over 200% YTD, yet I see little fundamental justification for its current $10B enterprise value. Click here to read why IBRX is a Sell.
Abstract: Stability analysis is needed to investigate the root causes of oscillations observed in modern power systems with increasing penetration of inverter-based resources (IBRs) globally.
The longevity industry has reached an inflection point. With companies like Function Health raising hundreds of millions in ...
Microplastic (MP) pollution poses a major concern, especially in aquatic environments, necessitating efficient detection technologies to safeguard marine life as well as human health. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results